Trends in Atherosclerotic Cardiovascular Disease and lipid management. A population-level observational cohort study in Wales.
Daniel E HarrisDaniel KingAshley AkbariMichael B GravenorMathew LawrenceClive WestonChris HopkinsLeighton PhillipsJulian P J HalcoxPublished in: European journal of preventive cardiology (2024)
Prescribing of LLT, including HI-statin therapy, documentation of LDL-C and achievement of target LDL-C levels was relatively low, especially in PAD patients. Although target achievement in "tested patients" increased over time, the proportion of patients undergoing lipid testing declined. More rigorous lipid management requires prioritisation, especially for PAD and stroke patients.
Keyphrases
- cardiovascular disease
- end stage renal disease
- patients undergoing
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- primary care
- coronary artery disease
- stem cells
- fatty acid
- emergency department
- metabolic syndrome
- cell therapy
- cardiovascular risk factors
- replacement therapy
- drug induced